Dr. Alexander Veloso, MD

Dr. Veloso practices at Endoscopy Center of Miami in Miami, Florida.

Dr. Veloso's NPI, 1851629109, was assigned on November 25, 2009. Dr. Veloso graduated from Universidad Central del Caribe School of Medicine in 2005. Dr. Veloso holds Florida license ME109542.

Dr. Veloso's primary practice is Endoscopy Center of Miami, at 5101 Sw 8th St, Miami, FL 33134. The practice phone is (305) 461-1881.

Dr. Veloso's primary practice is Endoscopy Center of Miami in Miami, Florida. Dr. Veloso is also affiliated with Jackson Memorial Hospital. The medical group on file is GastroMed. Dmand AI also links Dr. Veloso to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veloso practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Veloso's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Veloso is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Veloso is licensed in Florida.

Dmand AI lists acid reflux, chronic indigestion, colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Veloso treats.

CMS data shows 277 Medicare services from Dr. Veloso across 6 procedure codes in 2024, for 174 Medicare patients. Medicare paid $26,151 for them.

CMS counts 174 Medicare patients who saw Dr. Veloso in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Veloso's median patient age at 61, with 59% women.

In 2024, Dr. Veloso wrote 2,786 Medicare Part D claims for 1,060 patients. 72% of them were for generic drugs. CMS names the drug for 2,630 of them, across 36 drugs with 11 or more claims each, at $1,438,603 in total drug cost. In 2023, CMS named 2,483 claims across 33 drugs.

Dr. Veloso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Veloso, more than 64% of the clinicians it reports for that procedure.

Dmand AI links Dr. Veloso to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Colitis, Ulcerative and Colitis. Open Payments lists research payments to Dr. Veloso that name 1 trial.

CMS Open Payments shows 1,274 general payments to Dr. Veloso from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $5,004. It also lists 1 research payment totaling $357 in 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Veloso, most recently CMS Stage 1 EHR in 2013.

Dr. Veloso graduated from Universidad Central del Caribe School of Medicine in 2005. Dr. Veloso is a member of ACG.

Dr. Veloso is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.